BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25339212)

  • 21. Endocannabinoid signaling in the brain.
    Wilson RI; Nicoll RA
    Science; 2002 Apr; 296(5568):678-82. PubMed ID: 11976437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endocannabinoids and synaptic function in the CNS.
    Hashimotodani Y; Ohno-Shosaku T; Kano M
    Neuroscientist; 2007 Apr; 13(2):127-37. PubMed ID: 17404373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developmental changes in retrograde messengers involved in depolarization-induced suppression of excitation at parallel fiber-Purkinje cell synapses in rodents.
    Crepel F
    J Neurophysiol; 2007 Jan; 97(1):824-36. PubMed ID: 17108093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid rafts: a nexus for endocannabinoid signaling?
    McFarland MJ; Barker EL
    Life Sci; 2005 Aug; 77(14):1640-50. PubMed ID: 15978630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinoids inhibit the synaptic uptake of adenosine and dopamine in the rat and mouse striatum.
    Pandolfo P; Silveirinha V; dos Santos-Rodrigues A; Venance L; Ledent C; Takahashi RN; Cunha RA; Köfalvi A
    Eur J Pharmacol; 2011 Mar; 655(1-3):38-45. PubMed ID: 21266173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour.
    Laviolette SR; van der Kooy D
    Nat Rev Neurosci; 2004 Jan; 5(1):55-65. PubMed ID: 14708004
    [No Abstract]   [Full Text] [Related]  

  • 27. Transient receptor potential vanilloid channels functioning in transduction of osmotic stimuli.
    Liedtke W
    J Endocrinol; 2006 Dec; 191(3):515-23. PubMed ID: 17170210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocannabinoids contribute to metabotropic glutamate receptor-mediated inhibition of GABA release onto hippocampal CA3 pyramidal neurons in an isolated neuron/bouton preparation.
    Inada H; Maejima T; Nakahata Y; Yamaguchi J; Nabekura J; Ishibashi H
    Neuroscience; 2010 Feb; 165(4):1377-89. PubMed ID: 19961906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ca(2+)-assisted receptor-driven endocannabinoid release: mechanisms that associate presynaptic and postsynaptic activities.
    Hashimotodani Y; Ohno-Shosaku T; Kano M
    Curr Opin Neurobiol; 2007 Jun; 17(3):360-5. PubMed ID: 17419048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The endocannabinoid system and gut-brain signalling.
    Storr MA; Sharkey KA
    Curr Opin Pharmacol; 2007 Dec; 7(6):575-82. PubMed ID: 17904903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alcoholism: a systems approach from molecular physiology to addictive behavior.
    Spanagel R
    Physiol Rev; 2009 Apr; 89(2):649-705. PubMed ID: 19342616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The endocannabinoid system in gp120-mediated insults and HIV-associated dementia.
    Bari M; Rapino C; Mozetic P; Maccarrone M
    Exp Neurol; 2010 Jul; 224(1):74-84. PubMed ID: 20353779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fortress brain.
    Royall DR
    Med Hypotheses; 2013 Feb; 80(2):118-21. PubMed ID: 23265350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids.
    Oz M
    Pharmacol Ther; 2006 Jul; 111(1):114-44. PubMed ID: 16584786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases.
    Maccarrone M; Battista N; Centonze D
    Prog Neurobiol; 2007 Apr; 81(5-6):349-79. PubMed ID: 17276576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions between the cannabinoid and dopaminergic systems: evidence from animal studies.
    El Khoury MA; Gorgievski V; Moutsimilli L; Giros B; Tzavara ET
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jul; 38(1):36-50. PubMed ID: 22300746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synaptic plasticity: cold-shocked synapses.
    Carr F
    Nat Rev Neurosci; 2015 Mar; 16(3):124. PubMed ID: 25649475
    [No Abstract]   [Full Text] [Related]  

  • 38. Regulation of extrasynaptic glutamate levels as a pathophysiological mechanism in disorders of motivation and addiction.
    McCullumsmith RE; Sanacora G
    Neuropsychopharmacology; 2015 Jan; 40(1):254-5. PubMed ID: 25482181
    [No Abstract]   [Full Text] [Related]  

  • 39. Neurotransmission: Sticking the brakes on.
    Carr F
    Nat Rev Neurosci; 2015 Sep; 16(9):508-9. PubMed ID: 26265507
    [No Abstract]   [Full Text] [Related]  

  • 40. TRPV-ing up pain for a long life.
    Skaper SD
    CNS Neurol Disord Drug Targets; 2014; 13(6):926. PubMed ID: 25135189
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.